• #904177
  • Genentech USA #50242004413

Activase® Alteplase 50 mg Injection Single-Use Vial 29 Million IU

ACTIVASE 50MG VL

Features
  • Activase® (alteplase) is indicated for the treatment of acute ischemic stroke (AIS)
  • Activase® is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure
  • Activase® is indicated for the lysis of acute massive pulmonary embolism (PE)
  • More …
Log In to Order
or

Product Specifications


Features
  • Activase® (alteplase) is indicated for the treatment of acute ischemic stroke (AIS)
  • Activase® is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure
  • Activase® is indicated for the lysis of acute massive pulmonary embolism (PE)
  • Using a large bore needle (e.g., 18 gauge) and a syringe, reconstitute by adding the contents of the accompanying 50 mL vial of SWFI to the 50 mg vial of Activase, directing the SWFI stream into the lyophilized cake
More Information

Professionals Also Viewed